Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation

Molecular Biology of the Cell

Volumn 10, Issue 11, 1999, Pages 3801-3813

  Fujii, Makiko ^a   Takeda, Kohsuke ^a,b   Imamura, Takeshi ^a   Aoki, Hiromasa ^a   Sampath, T Kuber ^d   Enomoto, Shoji ^c   Kawabata, Masahiro ^a   Kato, Mitsuyasu ^a   Ichijo, Hidenori ^a,b   Miyazono, Kohei ^a  

^a JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^b Department of Biomaterials Science ^*  (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d CURIS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 1 RECEPTOR; PROTEIN SERINE THREONINE KINASE; SMAD PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CARTILAGE CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; RECEPTOR BINDING;

EID: 0032718990     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.10.11.3801     Document Type: Article

References (62)

1. Akiyama, S., Katagiri, T., Namiki, M., Yamaji, N., Yamamoto, N., Miyama, K., Shibuya, H., Ueno, N., Wozney, J.M., and Suda, T. (1997). Constitutively active BMP type I receptors transduce BMP-2 signals without the ligand in C2C12 myoblasts. Exp. Cell Res. 235, 362-369.
2. Armes, N.A., Neal, K.A., and Smith, J.C. (1999). A short loop on the ALK-2 and ALK-4 activin receptors regulates signaling specificity but cannot account for all their effects on early Xenopus development. J. Biol. Chem. 274, 7929-7935.
3. Armes, N.A., and Smith, J.C. (1997). The ALK-2 and ALK-4 activin receptors transduce distinct mesoderm-inducing signals during early Xenopus development but do not cooperate to establish thresholds. Development 124, 3797-3804.
4. Asahina, I., Sampath, T.K., and Hauschka, P.V. (1996). Human osteogenic protein-1 induces chondroblastic, osteoblastic, and/or adipocytic differentiation of clonal murine target cells. Exp. Cell Res. 222, 38-47.
5. Asahina, I., Sampath, T.K., Nishimura, I., and Hauschka, P.V. (1993). Human osteogenic protein-1 induces both chondroblastic and osteoblastic differentiation of osteoprogenitor cells derived from newborn rat calvaria. J. Cell Biol. 123, 921-933.
6. Atfi, A., Djelloul, S., Chastre, E., Davis, R., and Gespach, C. (1997). Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor β-mediated signaling. J. Biol. Chem. 272, 1429-1432.
7. Attisano, L., and Wrana, J.L. (1998). Mads and Smads in TGFβ signaling. Curr. Opin. Cell Biol. 10, 188-194.
8. Bhushan, A., Chen, Y., and Vale, W. (1998). Smad7 inhibits mesoderm formation and promotes neural cell fate in Xenopus embryos. Dev. Biol. 200, 260-268.
9. Chen, D., Ji, X., Harris, M.A., Feng, J.Q., Karsenty, G., Celeste, A.J., Rosen, V., Mundy, G.R., and Harris, S.E. (1998). Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J. Cell Biol. 142, 295-305.
10. Chen, Y.G., Hata, A., Lo, R.S., Wotton, D., Shi, Y., Pavletich, N., and Massagué, J. (1998). Determinants of specificity in TGF-β signal transduction. Genes Dev. 12, 2144-2152.
11. Chen, Y.G., and Massagué, J. (1999). Smad1 recognition and activation by the ALK1 group of transforming growth factor-β family receptors. J. Biol. Chem. 274, 3672-3677.
12. Derynck, R., Zhang, Y., and Feng, X.-H. (1998). Smads: transcriptional activators of TGF-β responses. Cell 95, 737-740.
13. Ebisawa, T., Tada, K., Kitajima, I., Tojo, A., Sampath, T.K., Kawabata, M., Miyazono, K., and Imamura, T. (1999). Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation. J. Cell Sci. (in press).
14. Feng, X.-H., and Derynck, R. (1997). A kinase subdomain of transforming growth factor-β (TGF-β) type I receptor determines the TGF-β intracellular signaling specificity. EMBO J. 16, 3912-3923.
15. Francis-West, P.H., Abdelfattah, A., Chen, P., Allen, C., Parish, J., Ladher, R., Allen, S., MacPherson, S., Luyten, F.P., and Archer, C.W. (1999). Mechanisms of GDF-5 action during skeletal development. Development 126, 1305-1315.
16. Gitelman, S.E., Kobrin, M.S., Ye, J.Q., Lopez, A.R., Lee, A., and Derynck, R. (1994). Recombinant Vgr-1/BMP-6-expressing tumors induce fibrosis and endochondral bone formation in vivo. J. Cell Biol. 126, 1595-1609.
17. Graff, J.M., Bansal, A., and Melton, D.A. (1996). Xenopus Mad proteins transduce distinct subsets of signals for the TGFβ superfamily. Cell 85, 479-487.
18. Hannigan, M., Zhan, L., Ai, Y., and Huang, C.-K. (1998). The role of p38 MAP kinase in TGF-β1-induced signal transduction in human neutrophils. Biochem. Biophys. Res. Commun. 246, 55-58.
19. mapk in proliferating cultures of epithelial cells. J. Biol. Chem. 270, 7117-7124.
20. Hata, A., Lagna, G., Massagué, J., and Hemmati-Brivanlou, A. (1998). Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev. 12, 186-197.
21. Hayashi, H., et al. (1997). The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling. Cell 89, 1165-1173.
22. Heldin, C.-H., Miyazono, K., and ten Dijke, P. (1997). TGF-β signaling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471.
23. Hocevar, B.A., Brown, T.L., and Howe, P.H. (1999). TGF-β induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J. 18, 1345-1356.
24. Hogan, B.L. (1996). Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 10, 1580-1594.
25. Hötten, G.C., et al. (1996). Recombinant human growth/differentiation factor 5 stimulates mesenchyme aggregation and chondrogenesis responsible for the skeletal development of limbs. Growth Factors 13, 65-74.
26. Imamura, T., Takase, M., Nishihara, A., Oeda, E., Hanai, J., Kawabata, M., and Miyazono, K. (1997). Smad6 inhibits signaling by the TGF-β superfamily. Nature 389, 622-626.
27. Itoh, S., Landström, M., Hermansson, A., Itoh, F., Heldin, C.-H., Heldin, N.-E., and ten Dijke, P. (1998). Transforming growth factor β1 induces nuclear export of inhibitory Smad7. J. Biol. Chem. 273, 29195-29201.
28. Katagiri, T., Yamaguchi, A., Komaki, M., Abe, E., Takahashi, N., Ikeda, T., Rosen, V., Wozney, J.M., Fujisawa-Sehara, A., and Suda, T. (1994). Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 127, 1755-1766.
29. Kawabata, M., Imamura, T., and Miyazono, K. (1998a). Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev. 9, 49-61.
30. Kawabata, M., Inoue, H., Hanyu, A., Imamura, T., and Miyazono, K. (1998b). Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors. EMBO J. 17, 4056-4065.
31. Liberati, N.T., Datto, M.B., Frederick, J.P., Shen, X., Wong, C., Rougier-Chapman, E.M., and Wang, X.-F. (1999). Smads bind directly to the Jun family of AP-1 transcription factors. Proc. Natl. Acad. Sci. USA 96, 4844-4849.
32. Lietman, S.A., Yanagishita, M., Sampath, T.K., and Reddi, A.H. (1997). Stimulation of proteoglycan synthesis in explants of porcine articular cartilage by recombinant osteogenic protein-1 (bone morphogenetic protein-7). J. Bone Joint Surg. Am. 79, 1132-1137.
33. Lo, R.S., Chen, Y.G., Shi, Y., Pavletich, N.P., and Massagué, J. (1998). The L3 loop: a structural motif determining specific interactions between SMAD proteins and TGF-β receptors. EMBO J. 17, 996-1005.
34. 1, and activin A enhance the cartilage phenotype of articular chondrocytes in vitro. Exp. Cell Res. 210, 224-229.
35. Macías-Silva, M., Hoodless, P.A., Tang, S.J., Buchwald, M., and Wrana, J.L. (1998). Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. J. Biol. Chem. 273, 25628-25636.
36. Massagué, J. (1998). TGF-β signal transduction. Annu. Rev. Biochem. 67, 753-791.
37. Miyake, S., Makimura, M., Kanegae, Y., Harada, S., Sato, Y., Takamori, K., Tokuda, C., and Saito, I. (1996). Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc. Natl. Acad. Sci. USA 93, 1320-1324.
38. Nakao, A., et al. (1997). Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signaling. Nature 389, 631-635.
39. Nakayama, T., Gardner, H., Berg, L.K., and Christian, J.L. (1998a). Smad6 functions as an intracellular antagonist of some TGF-β family members during Xenopus embryogenesis. Genes Cells 3, 387-394.
40. Nakayama, T., Snyder, M.A., Grewal, S.S., Tsuneizumi, K., Tabata, T., and Christian, J.L. (1998b). Xenopus Smad8 acts downstream of BMP-4 to modulate its activity during vertebrate embryonic patterning. Development 125, 857-867.
41. Namiki, M., Akiyama, S., Katagiri, T., Suzuki, A., Ueno, N., Yamaji, N., Rosen, V., Wozney, J.M., and Suda, T. (1997). A kinase domain-truncated type I receptor blocks bone morphogenetic protein-2-induced signal transduction in C2C12 myoblasts. J. Biol. Chem. 272, 22046-22052.
42. Nishitoh, H., Ichijo, H., Kimura, M., Matsumoto, T., Makishima, F., Yamaguchi, A., Yamashita, H., Enomoto, S., and Miyazono, K. (1996). Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5. J. Biol. Chem. 271, 21345-21352.
43. Persson, U., Izumi, H., Souchelnytskyi, S., Itoh, S., Grimsby, S., Engström, U., Heldin, C.-H., Funa, K., and ten Dijke, P. (1998). The L45 loop in type I receptors for TGF-β family members is a critical determinant in specifying Smad isoform activation. FEBS Lett. 434, 83-87.
44. Reddi, A.H. (1994). Bone and cartilage differentiation. Curr. Opin. Genet. Dev. 4, 737-744.
45. Rosen, V., Nove, J., Song, J.J., Thies, R.S., Cox, K., and Wozney, J.M. (1994). Responsiveness of clonal limb bud cell lines to bone morphogenetic protein 2 reveals a sequential relationship between cartilage and bone cell phenotypes. J. Bone Miner. Res. 9, 1759-1768.
46. Saito, I., Oya, Y., Yamamoto, K., Yuasa, T., and Shimojo, H. (1985). Construction of nondefective adenovirus type 5 bearing a 2.8-kb hepatitis B virus DNA near the right end of its genome. J. Virol. 54, 711-719.
47. Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y., Kawabata, M., Miyazono, K., and Ichijo, H. (1998). Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17, 2596-2606.
48. Sampath, T.K., et al. (1992). Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J. Biol. Chem. 267, 20352-20362.
49. Shukunami, C., Ohta, Y., Sakuda, M., and Hiraki, Y. (1998). Sequential progression of the differentiation program by bone morphogenetic protein-2 in chondrogenic cell line ATDC5. Exp. Cell Res. 241, 1-11.
50. Shukunami, C., Shigeno, C., Atsumi, T., Ishizeki, K., Suzuki, F., and Hiraki, Y. (1996). Chondrogenic differentiation of clonal mouse embryonic cell line ATDC5 in vitro: differentiation-dependent gene expression of parathyroid hormone (PTH)/PTH-related peptide receptor. J. Cell Biol. 133, 457-468.
51. Suzuki, A., Chang, C., Yingling, J.M., Wang, X.-F., and Hemmati-Brivanlou, A. (1997). Smad5 induces ventral fates in Xenopus embryo. Dev. Biol. 184, 402-405.
52. Takeda, K., Ichijo, H., Fujii, M., Mochida, Y., Saitoh, M., Nishitoh, H., Sampath, T.K., and Miyazono, K. (1998). Identification of a novel bone morphogenetic protein-responsive gene that may function as a noncoding RNA. J. Biol. Chem. 273, 17079-17085.
53. ten Dijke, P., Yamashita, H., Ichijo, H., Franzén, P., Laiho, M., Miyazono, K. and Heldin, C.-H. (1994a). Characterization of type I receptors for transforming growth factor-β and activin. Science 264, 101-104.
54. ten Dijke, P., Yamashita, H., Sampath, T.K., Reddi, A.H., Estevez, M., Riddle, D.L., Ichijo, H., Heldin, C.-H., and Miyazono, K. (1994b). Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J. Biol. Chem. 269, 16985-16988.
55. Thomsen, G.H. (1996). Xenopus mothers against decapentaplegic is an embryonic ventralizing agent that acts downstream of the BMP-2/4 receptor. Development 122, 2359-2366.
56. Tsumaki, N., Tanaka, K., Arikawa-Hirasawa, E., Nakase, T., Kimura, T., Thomas, J.T., Ochi, T., Luyten, F.P., and Yamada, Y. (1999). Role of CDMP-1 in skeletal morphogenesis: promotion of mesenchymal cell recruitment and chondrocyte differentiation. J. Cell Biol. 144, 161-173.
57. Wieser, R., Wrana, J.L., and Massagué, J. (1995). GS domain mutations that constitutively activate TβR-I, the downstream signaling component in the TGF-β receptor complex. EMBO J. 14, 2199-2208.
58. Wolfman, N.M., et al. (1997). Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7, members of the TGF-β gene family. J. Clin. Invest. 100, 321-330.
59. Wozney, J.M., Rosen, V., Celeste, A.J., Mitsock, L.M., Whitters, M.J., Kriz, R.W., Hewick, R.M., and Wang, E.A. (1988). Novel regulators of bone formation: molecular clones and activities. Science 242, 1528-1534.
60. Yagi, K., Goto, D., Hamamoto, T., Takenoshita, S., Kato, M., and Miyazono, K. (1999). Alternatively-spliced variant of Smad2 lacking exon 3: comparison with wild-type Smad2 and Smad3. J. Biol. Chem. 274, 703-709.
61. Yamamoto, N., Akiyama, S., Katagiri, T., Namiki, M., Kurokawa, T., and Suda, T. (1997). Smad1 and Smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts. Biochem. Biophys. Res. Commun. 238, 574-580.
62. Zou, H., Wieser, R., Massague, J., and Niswander, L. (1997). Distinct roles of type I bone morphogenetic protein receptors in the formation and differentiation of cartilage. Genes Dev. 11, 2191-2203.